What You Need To Know

• A core feature of the program is the “most-favored-nation” (MFN) pricing model, which requires drug manufacturers to match or beat the lowest prices paid in comparable wealthy countries.
• Cuban notes that sharing prices on TrumpRx will increase visibility, drive higher volumes, and allow further price reductions to benefit consumers.
• Pfizer was the first major pharmaceutical company to join TrumpRx, offering select drugs such as Eucrisa and Xeljanz at deep discounts.